Germline mutations in BRCA1 and BRCA2, the most known breast cancer susceptibility genes, compromise DNA repair by homologous recombination and over 75% of tumours arising in women who inherit these mutations have a triple-negative phenotype [17,18]. This evidence concerns the gene BRCA1 and breast cancer.